{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T06:48:32Z","timestamp":1789541312906,"version":"build-2803163510"},"reference-count":78,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,10]]},"abstract":"<jats:p>\n                    <jats:bold>Context.\u2014<\/jats:bold>\n                    The International Collaboration on Cancer Reporting is a not-for-profit organization formed by the Royal Colleges of Pathologists of Australasia and the United Kingdom; the College of American Pathologists; the Canadian Association of Pathologists\u2013Association Canadienne des Pathologists, in association with the Canadian Partnership Against Cancer; and the European Society of Pathology. Its goal is to produce common, internationally agreed upon, evidence-based datasets for use throughout the world.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Objective.\u2014<\/jats:bold>\n                    To describe a dataset developed by the Expert Panel of the International Collaboration on Cancer Reporting for reporting malignant mesothelioma of both the pleura and peritoneum. The dataset is composed of \u201crequired\u201d (mandatory) and \u201crecommended\u201d (nonmandatory) elements.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Design.\u2014<\/jats:bold>\n                    Based on a review of the most recent evidence and supported by explanatory commentary.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results.\u2014<\/jats:bold>\n                    Eight required elements and 7 recommended elements were agreed upon by the Expert Panel to represent the essential information for reporting malignant mesothelioma of the pleura and peritoneum.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusions.\u2014<\/jats:bold>\n                    In time, the widespread use of an internationally agreed upon, structured, pathology dataset for mesothelioma will lead not only to improved patient management but also provide valuable data for research and international benchmarks.\n                  <\/jats:p>","DOI":"10.5858\/arpa.2016-0073-oa","type":"journal-article","created":{"date-parts":[[2016,3,31]],"date-time":"2016-03-31T11:28:47Z","timestamp":1459423727000},"page":"1104-1110","source":"Crossref","is-referenced-by-count":24,"title":["Dataset for Reporting of Malignant Mesothelioma of the Pleura or Peritoneum: Recommendations From the International Collaboration on Cancer Reporting (ICCR)"],"prefix":"10.5858","volume":"140","author":[{"given":"Andrew","family":"Churg","sequence":"first","affiliation":[{"name":"From the Department of Pathology and Laboratory Medicine, University of British Columbia, and Vancouver General Hospital, Vancouver, British Columbia, Canada (Dr Churg); the Department of Cellular Pathology, Cardiff and Vale University Health Board, University Hospital of Wales, Cardiff, United Kingdom (Drs Attanoos and Gibbs); the Department of Pathology, Weill Cornell University Medical Center, New York, New York (Dr Borczuk); the Department of Pathology..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Attanoos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain C.","family":"Borczuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucian R.","family":"Chirieac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Galateau-Sall\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen","family":"Gibbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Roggli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Rusch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meagan J.","family":"Judge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Srigley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3906","reference":[{"issue":"6","key":"i1543-2165-140-10-1104-b01","series-title":"J Clin Oncol","first-page":"481","article-title":"The effect of four interventions on the informational content of histopathology reports of resected colorectal carcinomas","volume":"51","author":"Cross \n              SS,","year":"1998","unstructured":"Cross \n              SS, \n            \n            \n              Feeley \n              KM, \n            \n            \n              Angel \n              CA. \n            \n          \n          The effect of four interventions on the informational content of histopathology reports of resected colorectal carcinomas. J Clin Oncol. 1998;51(6):481\u2013482."},{"issue":"10","key":"i1543-2165-140-10-1104-b02","series-title":"J Clin Pathol","first-page":"809","article-title":"The use of a standard proforma in breast cancer reporting","volume":"54","author":"Mathers \n              M,","year":"2001","unstructured":"Mathers \n              M, \n            \n            \n              Shrimankar \n              J, \n            \n            \n              Scott \n              D, \n            \n            \n              Charlton \n              F, \n            \n            \n              Griffith \n              C, \n            \n            \n              Angus \n              B. \n            \n          \n          The use of a standard proforma in breast cancer reporting. J Clin Pathol. 2001;54(10):809\u2013811."},{"issue":"8","key":"i1543-2165-140-10-1104-b03","series-title":"J Surg Oncol","first-page":"517","article-title":"Standardized synoptic cancer pathology reporting: a population-based approach","volume":"99","author":"Srigley \n              JR,","year":"2009","unstructured":"Srigley \n              JR, \n            \n            \n              McGowan \n              T, \n            \n            \n              MacLean \n              A, \n            \n            et al. \n          Standardized synoptic cancer pathology reporting: a population-based approach. J Surg Oncol. 2009;99(8):517\u2013524."},{"issue":"2","key":"i1543-2165-140-10-1104-b04","series-title":"Pathology","first-page":"161","article-title":"New South Wales Pancreatic Cancer Network (NSWPCN). Synoptic reporting improves histopathological assessment of pancreatic resection specimens","volume":"41","author":"Gill \n              AJ,","year":"2009","unstructured":"Gill \n              AJ, \n            \n            \n              Johns \n              AL, \n            \n            \n              Eckstein \n              R, \n            \n            et al;\n          \n          New South Wales Pancreatic Cancer Network (NSWPCN). Synoptic reporting improves histopathological assessment of pancreatic resection specimens. Pathology. 2009;41(2):161\u2013167."},{"key":"i1543-2165-140-10-1104-b05","article-title":"Cancer datasets and tissue pathways. 2015","year":"2016","unstructured":"Royal College of Pathologists. Cancer datasets and tissue pathways. 2015. http:\/\/www.rcpath.org\/profession\/publications\/cancer-datasets.html. Accessed February 19, 2016."},{"key":"i1543-2165-140-10-1104-b06","article-title":"Cancer protocol templates","year":"2016","unstructured":"College of American Pathologists. Cancer protocol templates. http:\/\/www.cap.org\/web\/home\/resources\/cancer-reporting-tools\/cancer-protocol-templates?_adf.ctrl-state=10jd5draq2_17&_afrLoop=78742816534289#!%40%40%3F_afrLoop%3D78742816534289%26_adf.ctrl-state%3D4596lsm96_4. Accessed February 19, 2016."},{"key":"i1543-2165-140-10-1104-b07","article-title":"Cancer Protocols","year":"2016","unstructured":"Royal College of Pathologists of Australasia. Cancer Protocols. http:\/\/www.rcpa.edu.au\/Library\/Practising-Pathology\/Structured-Pathology-Reporting-of-Cancer\/Cancer-Protocols. Accessed February 19, 2016."},{"issue":"12","key":"i1543-2165-140-10-1104-b08","series-title":"Am J Surg Pathol","first-page":"1797","article-title":"International Collaboration on Cancer Reporting. Data set for pathology reporting of cutaneous invasive melanoma: recommendations from the International Collaboration on Cancer Reporting (ICCR)","volume":"37","author":"Scolyer \n              RA,","year":"2013","unstructured":"Scolyer \n              RA, \n            \n            \n              Judge \n              MJ, \n            \n            \n              Evans \n              A, \n            \n            et al;\n          \n          International Collaboration on Cancer Reporting. Data set for pathology reporting of cutaneous invasive melanoma: recommendations from the International Collaboration on Cancer Reporting (ICCR). Am J Surg Pathol. 2013;37(12):1797\u20131814."},{"issue":"1","key":"i1543-2165-140-10-1104-b09","series-title":"Int J Gynecol Pathol","first-page":"45","article-title":"Duggan, et al. Data set for reporting of endometrial carcinomas: recommendations from the International Collaboration on Cancer Reporting (ICCR) between United Kingdom, United States, Canada, and Australasia","volume":"32","author":"McCluggage \n              WG,","year":"2012","unstructured":"McCluggage \n              WG, \n            \n            \n              Colgan \n              T, \n            \n          \n          Duggan, et al. Data set for reporting of endometrial carcinomas: recommendations from the International Collaboration on Cancer Reporting (ICCR) between United Kingdom, United States, Canada, and Australasia. Int J Gynecol Pathol. 2012;32(1):45\u201365."},{"issue":"8","key":"i1543-2165-140-10-1104-b10","series-title":"Arch Pathol Lab Med","first-page":"1054","article-title":"Data set for reporting of lung carcinomas: recommendations from International Collaboration on Cancer Reporting","volume":"137","author":"Jones \n              KD,","year":"2013","unstructured":"Jones \n              KD, \n            \n            \n              Churg \n              A, \n            \n            \n              Henderson \n              DW, \n            \n            et al. \n          Data set for reporting of lung carcinomas: recommendations from International Collaboration on Cancer Reporting. Arch Pathol Lab Med. 2013;137(8):1054\u20131062."},{"issue":"8","key":"i1543-2165-140-10-1104-b11","series-title":"Mod Pathol","first-page":"1101","article-title":"Data set for reporting of ovary, fallopian tube and primary peritoneal carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR)","volume":"28","author":"McCluggage \n              WG,","year":"2015","unstructured":"McCluggage \n              WG, \n            \n            \n              Judge \n              MJ, \n            \n            \n              Clarke \n              BA, \n            \n            et al. \n          Data set for reporting of ovary, fallopian tube and primary peritoneal carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR). Mod Pathol2015;28(8):1101\u20131122."},{"issue":"2","key":"i1543-2165-140-10-1104-b12","series-title":"Histopathology","first-page":"203","article-title":"Dataset for reporting of prostate carcinoma in radical prostatectomy specimens: recommendations from the International Collaboration on Cancer Reporting","volume":"62","author":"Kench \n              J,","year":"2013","unstructured":"Kench \n              J, \n            \n            \n              Delahunt \n              B, \n            \n            \n              Griffiths \n              DF, \n            \n            et al. \n          Dataset for reporting of prostate carcinoma in radical prostatectomy specimens: recommendations from the International Collaboration on Cancer Reporting. Histopathology2013;62(2):203\u2013218."},{"key":"i1543-2165-140-10-1104-b13","series-title":"WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart. 4th ed","author":"Travis \n              WD,","year":"2015","unstructured":"Travis \n              WD, \n            \n            \n              Brambilla \n              E, \n            \n            \n              Burke \n              AP, \n            \n            \n              Marx \n              A, \n            \n            \n              Nicholson \n              AG, \n            \n          \n          eds. WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart. 4th ed. Lyon, France: IARC Press;2015. World Health Organization Classification of Tumours; vol 7."},{"key":"i1543-2165-140-10-1104-b14","first-page":"34","volume":"9","author":"Merlin \n              T,","year":"2009","unstructured":"Merlin \n              T, \n            \n            \n              Weston \n              A, \n            \n            \n              Tooher \n              R. \n            \n          \n          Extending an evidence hierarchy to include topics other than treatment: revising the Australian \u2018levels of evidence.' BMC Med Res Methodol. 2009;9:34."},{"issue":"6","key":"i1543-2165-140-10-1104-b15","series-title":"J Thorac Dis","first-page":"E254","article-title":"Guidelines for the diagnosis and treatment of malignant pleural mesothelioma","volume":"5","author":"van Zandwijk \n              N,","year":"2013","unstructured":"van Zandwijk \n              N, \n            \n            \n              Clarke \n              C, \n            \n            \n              Henderson \n              D, \n            \n            et al. \n          Guidelines for the diagnosis and treatment of malignant pleural mesothelioma. J Thorac Dis. 2013;5(6):E254\u2013307."},{"issue":"5","key":"i1543-2165-140-10-1104-b16","series-title":"Ann Thorac Surg","first-page":"1774","article-title":"Pleural biopsy: a reliable method for determining the diagnosis but not subtype in mesothelioma","volume":"78","author":"Bueno \n              R,","year":"2004","unstructured":"Bueno \n              R, \n            \n            \n              Reblando \n              J, \n            \n            \n              Glickman \n              J, \n            \n            \n              Jaklitsch \n              MT, \n            \n            \n              Lukanich \n              JM, \n            \n            \n              Sugarbaker \n              DJ. \n            \n          \n          Pleural biopsy: a reliable method for determining the diagnosis but not subtype in mesothelioma. Ann Thorac Surg. 2004;78(5):1774\u20131776."},{"issue":"10","key":"i1543-2165-140-10-1104-b17","series-title":"Cancer","first-page":"2248","article-title":"Accuracy of pleural biopsy using thoracoscopy for the diagnosis of histologic subtype in patients with malignant pleural mesothelioma","volume":"110","author":"Greillier \n              L,","year":"2007","unstructured":"Greillier \n              L, \n            \n            \n              Cavailles \n              A, \n            \n            \n              Fraticelli \n              A, \n            \n            et al. \n          Accuracy of pleural biopsy using thoracoscopy for the diagnosis of histologic subtype in patients with malignant pleural mesothelioma. Cancer. 2007;110(10):2248\u20132252."},{"issue":"3","key":"i1543-2165-140-10-1104-b18","series-title":"Histopathology","first-page":"340","article-title":"The comparative accuracy of different pleural biopsy techniques in the diagnosis of malignant mesothelioma","volume":"53","author":"Attanoos \n              RL,","year":"2008","unstructured":"Attanoos \n              RL, \n            \n            \n              Gibbs \n              AR. \n            \n          \n          The comparative accuracy of different pleural biopsy techniques in the diagnosis of malignant mesothelioma. Histopathology. 2008;53(3):340\u2013344."},{"issue":"3","key":"i1543-2165-140-10-1104-b19","series-title":"J Thorac Oncol","first-page":"602","article-title":"Accuracy of diagnostic biopsy for the histological subtype of malignant pleural mesothelioma","volume":"6","author":"Kao \n              SC,","year":"2011","unstructured":"Kao \n              SC, \n            \n            \n              Yan \n              TD, \n            \n            \n              Lee \n              K, \n            \n            et al. \n          Accuracy of diagnostic biopsy for the histological subtype of malignant pleural mesothelioma. J Thorac Oncol. 2011;6(3):602\u2013605."},{"issue":"5","key":"i1543-2165-140-10-1104-b20","series-title":"Arch Pathol Lab Med","first-page":"647","article-title":"International Mesothelioma Interest Group. Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group","volume":"137","author":"Husain \n              AN,","year":"2013","unstructured":"Husain \n              AN, \n            \n            \n              Colby \n              T, \n            \n            \n              Ordonez \n              N, \n            \n            et al;\n          \n          International Mesothelioma Interest Group. Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med. 2013;137(5):647\u2013667."},{"issue":"10","key":"i1543-2165-140-10-1104-b21","series-title":"Am J Surg Pathol","first-page":"1264","article-title":"Benign mesothelial cells in mediastinal lymph nodes","volume":"23","author":"Parkash \n              V,","year":"1999","unstructured":"Parkash \n              V, \n            \n            \n              Vidwans \n              M, \n            \n            \n              Carter \n              D. \n            \n          \n          Benign mesothelial cells in mediastinal lymph nodes. Am J Surg Pathol. 1999;23(10):1264\u20131269."},{"issue":"2","key":"i1543-2165-140-10-1104-b22","series-title":"Indian J Med Paediatr Oncol","first-page":"62","article-title":"Mesothelial cell inclusions mimicking adenocarcinoma in cervical lymph nodes in association with chylous effusion","volume":"31","author":"Goyal \n              M,","year":"2010","unstructured":"Goyal \n              M, \n            \n            \n              Kodandapani \n              S, \n            \n            \n              Sharanabasappa \n              SN, \n            \n            \n              Palanki \n              SD. \n            \n          \n          Mesothelial cell inclusions mimicking adenocarcinoma in cervical lymph nodes in association with chylous effusion. Indian J Med Paediatr Oncol. 2010;31(2):62\u201364."},{"issue":"2","key":"i1543-2165-140-10-1104-b23","series-title":"Semin Diagn Pathol","first-page":"89","article-title":"Medicolegal liability in surgical pathology: a consideration of underlying causes and selected pertinent concepts","volume":"24","author":"Wick \n              MR.","year":"2007","unstructured":"Wick \n              MR. \n            \n          \n          Medicolegal liability in surgical pathology: a consideration of underlying causes and selected pertinent concepts. Semin Diagn Pathol. 2007;24(2):89\u201397."},{"issue":"3","key":"i1543-2165-140-10-1104-b24","series-title":"Eur Respir J","first-page":"754","article-title":"Multimodal management of malignant pleural mesothelioma: where are we today?","volume":"44","author":"Van Schil \n              PE,","year":"2014","unstructured":"Van Schil \n              PE, \n            \n            \n              Opitz \n              I, \n            \n            \n              Weder \n              W, \n            \n            et al. \n          Multimodal management of malignant pleural mesothelioma: where are we today?\n          Eur Respir J. 2014;44(3):754\u2013764."},{"issue":"9","key":"i1543-2165-140-10-1104-b25","series-title":"J Clin Oncol","first-page":"1413","article-title":"Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma","volume":"27","author":"de Perrot \n              M,","year":"2009","unstructured":"de Perrot \n              M, \n            \n            \n              Feld \n              R, \n            \n            \n              Cho \n              BC, \n            \n            et al. \n          Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. J Clin Oncol. 2009;27(9):1413\u20131418."},{"issue":"9","key":"i1543-2165-140-10-1104-b26","series-title":"Clin Cancer Res","first-page":"3303","article-title":"P16 loss and mitotic activity predict poor survival in patients with peritoneal malignant mesothelioma","volume":"11","author":"Borczuk \n              AC,","year":"2005","unstructured":"Borczuk \n              AC, \n            \n            \n              Taub \n              RN, \n            \n            \n              Hesdorffer \n              M, \n            \n            et al. \n          P16 loss and mitotic activity predict poor survival in patients with peritoneal malignant mesothelioma. Clin Cancer Res. 2005;11(9):3303\u20133308."},{"issue":"5","key":"i1543-2165-140-10-1104-b27","series-title":"Histopathology","first-page":"729","article-title":"Prognostic significance of morphologic subtypes and mitotic index of epithelioid malignant peritoneal mesothelioma","volume":"68","author":"Krasinskas \n              AM,","year":"2016","unstructured":"Krasinskas \n              AM, \n            \n            \n              Borczuk \n              AC, \n            \n            \n              Hartman \n              DJ, \n            \n            et al. \n          Prognostic significance of morphologic subtypes and mitotic index of epithelioid malignant peritoneal mesothelioma. Histopathology. 2016;68(5):729\u2013737."},{"issue":"7","key":"i1543-2165-140-10-1104-b28","series-title":"Hum Pathol","first-page":"585","article-title":"The second diagnosis: the role of the pathologist in identifying pneumoconioses in lungs excised for tumor","volume":"12","author":"Mark \n              EJ.","year":"1981","unstructured":"Mark \n              EJ. \n            \n          \n          The second diagnosis: the role of the pathologist in identifying pneumoconioses in lungs excised for tumor. Hum Pathol. 1981;12(7):585\u2013587."},{"issue":"3","key":"i1543-2165-140-10-1104-b29","series-title":"Arch Pathol Lab Med","first-page":"462","article-title":"Pathology of asbestosis\u2014an update of the diagnostic criteria: report of the asbestosis committee of the College of American Pathologists and Pulmonary Pathology Society","volume":"134","author":"Roggli \n              VL,","year":"2010","unstructured":"Roggli \n              VL, \n            \n            \n              Gibbs \n              AR, \n            \n            \n              Attanoos \n              R, \n            \n            et al. \n          Pathology of asbestosis\u2014an update of the diagnostic criteria: report of the asbestosis committee of the College of American Pathologists and Pulmonary Pathology Society. Arch Pathol Lab Med. 2010;134(3):462\u2013480."},{"issue":"4","key":"i1543-2165-140-10-1104-b30","series-title":"Arch Pathol Lab Med","first-page":"318","article-title":"New markers for separating benign from malignant mesothelial proliferations: are we there yet","volume":"140","author":"Churg \n              A,","year":"2016","unstructured":"Churg \n              A, \n            \n            \n              Sheffield \n              BS, \n            \n            \n              Galateau-Salle \n              F. \n            \n          \n          New markers for separating benign from malignant mesothelial proliferations: are we there yet. Arch Pathol Lab Med. 2016;140(4):318\u2013321."},{"issue":"6","key":"i1543-2165-140-10-1104-b31","series-title":"Virchows Arch","first-page":"627","article-title":"Prognostic significance of p16\/CDKN2A loss in pleural malignant mesotheliomas","volume":"453","author":"Dacic \n              S,","year":"2008","unstructured":"Dacic \n              S, \n            \n            \n              Kothmaier \n              H, \n            \n            \n              Land \n              S, \n            \n            et al. \n          Prognostic significance of p16\/CDKN2A loss in pleural malignant mesotheliomas. Virchows Arch. 2008;453(6):627\u2013635."},{"issue":"6","key":"i1543-2165-140-10-1104-b32","series-title":"Cancer Res","first-page":"2970","article-title":"Global gene expression profiling of pleural mesotheliomas: overexpression of aurora kinases and P16\/CDKN2A deletion as prognostic factors and critical evaluation of microarray-based prognostic prediction","volume":"66","author":"Lopez-Rios \n              F,","year":"2006","unstructured":"Lopez-Rios \n              F, \n            \n            \n              Chuai \n              S, \n            \n            \n              Flores \n              R, \n            \n            et al. \n          Global gene expression profiling of pleural mesotheliomas: overexpression of aurora kinases and P16\/CDKN2A deletion as prognostic factors and critical evaluation of microarray-based prognostic prediction. Cancer Res. 2006;66(6):2970\u20132979."},{"issue":"3","key":"i1543-2165-140-10-1104-b33","series-title":"Nat Rev Cancer","first-page":"153","article-title":"BAP1 and cancer","volume":"13","author":"Carbone \n              M,","year":"2013","unstructured":"Carbone \n              M, \n            \n            \n              Yang \n              H, \n            \n            \n              Pass \n              HI, \n            \n            \n              Krausz \n              T, \n            \n            \n              Testa \n              JR, \n            \n            \n              Gaudino \n              G. \n            \n          \n          BAP1 and cancer. Nat Rev Cancer. 2013;13(3):153\u2013159."},{"issue":"1","key":"i1543-2165-140-10-1104-b34","series-title":"Carcinogenesis","first-page":"76","article-title":"Mesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survival","volume":"36","author":"Baumann \n              F,","year":"2015","unstructured":"Baumann \n              F, \n            \n            \n              Flores \n              E, \n            \n            \n              Napolitano \n              A, \n            \n            et al. \n          Mesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survival. Carcinogenesis. 2015;36(1):76\u201381."},{"issue":"1","key":"i1543-2165-140-10-1104-b35","series-title":"Am J Clin Pathol","first-page":"85","article-title":"Comparative immunohistochemical analysis of IMP3, GLUT1, EMA, CD146, and desmin for distinguishing malignant mesothelioma from reactive mesothelial cells","volume":"141","author":"Minato \n              H,","year":"2014","unstructured":"Minato \n              H, \n            \n            \n              Kurose \n              N, \n            \n            \n              Fukushima \n              M, \n            \n            et al. \n          Comparative immunohistochemical analysis of IMP3, GLUT1, EMA, CD146, and desmin for distinguishing malignant mesothelioma from reactive mesothelial cells. Am J Clin Pathol. 2014;141(1):85\u201393."},{"issue":"7","key":"i1543-2165-140-10-1104-b36","series-title":"Arch Pathol Lab Med","first-page":"804","article-title":"Utility of glucose transporter 1 in the distinction of benign and malignant thoracic and abdominal mesothelial lesions","volume":"136","author":"Lagana \n              SM,","year":"2012","unstructured":"Lagana \n              SM, \n            \n            \n              Taub \n              RN, \n            \n            \n              Borczuk \n              AC. \n            \n          \n          Utility of glucose transporter 1 in the distinction of benign and malignant thoracic and abdominal mesothelial lesions. Arch Pathol Lab Med. 2012;136(7):804\u2013809."},{"issue":"4","key":"i1543-2165-140-10-1104-b37","series-title":"Am J Clin Pathol","first-page":"619","article-title":"The diagnostic utility of p16 FISH and GLUT-1 immunohistochemical analysis in mesothelial proliferations","volume":"135","author":"Monaco \n              SE,","year":"2011","unstructured":"Monaco \n              SE, \n            \n            \n              Shuai \n              Y, \n            \n            \n              Bansal \n              M, \n            \n            \n              Krasinskas \n              AM, \n            \n            \n              Dacic \n              S. \n            \n          \n          The diagnostic utility of p16 FISH and GLUT-1 immunohistochemical analysis in mesothelial proliferations. Am J Clin Pathol. 2011;135(4):619\u2013627."},{"issue":"3","key":"i1543-2165-140-10-1104-b38","series-title":"Am J Surg Pathol","first-page":"421","article-title":"IMP3 and GLUT-1 immunohistochemistry for distinguishing benign from malignant mesothelial proliferations","volume":"37","author":"Lee \n              AF,","year":"2013","unstructured":"Lee \n              AF, \n            \n            \n              Gown \n              AM, \n            \n            \n              Churg \n              A. \n            \n          \n          IMP3 and GLUT-1 immunohistochemistry for distinguishing benign from malignant mesothelial proliferations. Am J Surg Pathol. 2013;37(3):421\u2013426."},{"issue":"7","key":"i1543-2165-140-10-1104-b39","series-title":"Am J Surg Pathol","first-page":"866","article-title":"Localized malignant mesothelioma","volume":"29","author":"Allen \n              TC,","year":"2005","unstructured":"Allen \n              TC, \n            \n            \n              Cagle \n              PT, \n            \n            \n              Churg \n              AM, \n            \n            et al. \n          Localized malignant mesothelioma. Am J Surg Pathol. 2005;29(7):866\u2013873."},{"issue":"6","key":"i1543-2165-140-10-1104-b01","series-title":"J Clin Oncol","first-page":"481","article-title":"The effect of four interventions on the informational content of histopathology reports of resected colorectal carcinomas","volume":"51","author":"Cross \n              SS,","year":"1998","unstructured":"Cross \n              SS, \n            \n            \n              Feeley \n              KM, \n            \n            \n              Angel \n              CA. \n            \n          \n          The effect of four interventions on the informational content of histopathology reports of resected colorectal carcinomas. J Clin Oncol. 1998;51(6):481\u2013482."},{"issue":"10","key":"i1543-2165-140-10-1104-b02","series-title":"J Clin Pathol","first-page":"809","article-title":"The use of a standard proforma in breast cancer reporting","volume":"54","author":"Mathers \n              M,","year":"2001","unstructured":"Mathers \n              M, \n            \n            \n              Shrimankar \n              J, \n            \n            \n              Scott \n              D, \n            \n            \n              Charlton \n              F, \n            \n            \n              Griffith \n              C, \n            \n            \n              Angus \n              B. \n            \n          \n          The use of a standard proforma in breast cancer reporting. J Clin Pathol. 2001;54(10):809\u2013811."},{"issue":"8","key":"i1543-2165-140-10-1104-b03","series-title":"J Surg Oncol","first-page":"517","article-title":"Standardized synoptic cancer pathology reporting: a population-based approach","volume":"99","author":"Srigley \n              JR,","year":"2009","unstructured":"Srigley \n              JR, \n            \n            \n              McGowan \n              T, \n            \n            \n              MacLean \n              A, \n            \n            et al. \n          Standardized synoptic cancer pathology reporting: a population-based approach. J Surg Oncol. 2009;99(8):517\u2013524."},{"issue":"2","key":"i1543-2165-140-10-1104-b04","series-title":"Pathology","first-page":"161","article-title":"New South Wales Pancreatic Cancer Network (NSWPCN). Synoptic reporting improves histopathological assessment of pancreatic resection specimens","volume":"41","author":"Gill \n              AJ,","year":"2009","unstructured":"Gill \n              AJ, \n            \n            \n              Johns \n              AL, \n            \n            \n              Eckstein \n              R, \n            \n            et al;\n          \n          New South Wales Pancreatic Cancer Network (NSWPCN). Synoptic reporting improves histopathological assessment of pancreatic resection specimens. Pathology. 2009;41(2):161\u2013167."},{"key":"i1543-2165-140-10-1104-b05","article-title":"Cancer datasets and tissue pathways. 2015","year":"2016","unstructured":"Royal College of Pathologists. Cancer datasets and tissue pathways. 2015. http:\/\/www.rcpath.org\/profession\/publications\/cancer-datasets.html. Accessed February 19, 2016."},{"key":"i1543-2165-140-10-1104-b06","article-title":"Cancer protocol templates","year":"2016","unstructured":"College of American Pathologists. Cancer protocol templates. http:\/\/www.cap.org\/web\/home\/resources\/cancer-reporting-tools\/cancer-protocol-templates?_adf.ctrl-state=10jd5draq2_17&_afrLoop=78742816534289#!%40%40%3F_afrLoop%3D78742816534289%26_adf.ctrl-state%3D4596lsm96_4. Accessed February 19, 2016."},{"key":"i1543-2165-140-10-1104-b07","article-title":"Cancer Protocols","year":"2016","unstructured":"Royal College of Pathologists of Australasia. Cancer Protocols. http:\/\/www.rcpa.edu.au\/Library\/Practising-Pathology\/Structured-Pathology-Reporting-of-Cancer\/Cancer-Protocols. Accessed February 19, 2016."},{"issue":"12","key":"i1543-2165-140-10-1104-b08","series-title":"Am J Surg Pathol","first-page":"1797","article-title":"International Collaboration on Cancer Reporting. Data set for pathology reporting of cutaneous invasive melanoma: recommendations from the International Collaboration on Cancer Reporting (ICCR)","volume":"37","author":"Scolyer \n              RA,","year":"2013","unstructured":"Scolyer \n              RA, \n            \n            \n              Judge \n              MJ, \n            \n            \n              Evans \n              A, \n            \n            et al;\n          \n          International Collaboration on Cancer Reporting. Data set for pathology reporting of cutaneous invasive melanoma: recommendations from the International Collaboration on Cancer Reporting (ICCR). Am J Surg Pathol. 2013;37(12):1797\u20131814."},{"issue":"1","key":"i1543-2165-140-10-1104-b09","series-title":"Int J Gynecol Pathol","first-page":"45","article-title":"Duggan, et al. Data set for reporting of endometrial carcinomas: recommendations from the International Collaboration on Cancer Reporting (ICCR) between United Kingdom, United States, Canada, and Australasia","volume":"32","author":"McCluggage \n              WG,","year":"2012","unstructured":"McCluggage \n              WG, \n            \n            \n              Colgan \n              T, \n            \n          \n          Duggan, et al. Data set for reporting of endometrial carcinomas: recommendations from the International Collaboration on Cancer Reporting (ICCR) between United Kingdom, United States, Canada, and Australasia. Int J Gynecol Pathol. 2012;32(1):45\u201365."},{"issue":"8","key":"i1543-2165-140-10-1104-b10","series-title":"Arch Pathol Lab Med","first-page":"1054","article-title":"Data set for reporting of lung carcinomas: recommendations from International Collaboration on Cancer Reporting","volume":"137","author":"Jones \n              KD,","year":"2013","unstructured":"Jones \n              KD, \n            \n            \n              Churg \n              A, \n            \n            \n              Henderson \n              DW, \n            \n            et al. \n          Data set for reporting of lung carcinomas: recommendations from International Collaboration on Cancer Reporting. Arch Pathol Lab Med. 2013;137(8):1054\u20131062."},{"issue":"8","key":"i1543-2165-140-10-1104-b11","series-title":"Mod Pathol","first-page":"1101","article-title":"Data set for reporting of ovary, fallopian tube and primary peritoneal carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR)","volume":"28","author":"McCluggage \n              WG,","year":"2015","unstructured":"McCluggage \n              WG, \n            \n            \n              Judge \n              MJ, \n            \n            \n              Clarke \n              BA, \n            \n            et al. \n          Data set for reporting of ovary, fallopian tube and primary peritoneal carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR). Mod Pathol2015;28(8):1101\u20131122."},{"issue":"2","key":"i1543-2165-140-10-1104-b12","series-title":"Histopathology","first-page":"203","article-title":"Dataset for reporting of prostate carcinoma in radical prostatectomy specimens: recommendations from the International Collaboration on Cancer Reporting","volume":"62","author":"Kench \n              J,","year":"2013","unstructured":"Kench \n              J, \n            \n            \n              Delahunt \n              B, \n            \n            \n              Griffiths \n              DF, \n            \n            et al. \n          Dataset for reporting of prostate carcinoma in radical prostatectomy specimens: recommendations from the International Collaboration on Cancer Reporting. Histopathology2013;62(2):203\u2013218."},{"key":"i1543-2165-140-10-1104-b13","series-title":"WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart. 4th ed","author":"Travis \n              WD,","year":"2015","unstructured":"Travis \n              WD, \n            \n            \n              Brambilla \n              E, \n            \n            \n              Burke \n              AP, \n            \n            \n              Marx \n              A, \n            \n            \n              Nicholson \n              AG, \n            \n          \n          eds. WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart. 4th ed. Lyon, France: IARC Press;2015. World Health Organization Classification of Tumours; vol 7."},{"key":"i1543-2165-140-10-1104-b14","first-page":"34","volume":"9","author":"Merlin \n              T,","year":"2009","unstructured":"Merlin \n              T, \n            \n            \n              Weston \n              A, \n            \n            \n              Tooher \n              R. \n            \n          \n          Extending an evidence hierarchy to include topics other than treatment: revising the Australian \u2018levels of evidence.' BMC Med Res Methodol. 2009;9:34."},{"issue":"6","key":"i1543-2165-140-10-1104-b15","series-title":"J Thorac Dis","first-page":"E254","article-title":"Guidelines for the diagnosis and treatment of malignant pleural mesothelioma","volume":"5","author":"van Zandwijk \n              N,","year":"2013","unstructured":"van Zandwijk \n              N, \n            \n            \n              Clarke \n              C, \n            \n            \n              Henderson \n              D, \n            \n            et al. \n          Guidelines for the diagnosis and treatment of malignant pleural mesothelioma. J Thorac Dis. 2013;5(6):E254\u2013307."},{"issue":"5","key":"i1543-2165-140-10-1104-b16","series-title":"Ann Thorac Surg","first-page":"1774","article-title":"Pleural biopsy: a reliable method for determining the diagnosis but not subtype in mesothelioma","volume":"78","author":"Bueno \n              R,","year":"2004","unstructured":"Bueno \n              R, \n            \n            \n              Reblando \n              J, \n            \n            \n              Glickman \n              J, \n            \n            \n              Jaklitsch \n              MT, \n            \n            \n              Lukanich \n              JM, \n            \n            \n              Sugarbaker \n              DJ. \n            \n          \n          Pleural biopsy: a reliable method for determining the diagnosis but not subtype in mesothelioma. Ann Thorac Surg. 2004;78(5):1774\u20131776."},{"issue":"10","key":"i1543-2165-140-10-1104-b17","series-title":"Cancer","first-page":"2248","article-title":"Accuracy of pleural biopsy using thoracoscopy for the diagnosis of histologic subtype in patients with malignant pleural mesothelioma","volume":"110","author":"Greillier \n              L,","year":"2007","unstructured":"Greillier \n              L, \n            \n            \n              Cavailles \n              A, \n            \n            \n              Fraticelli \n              A, \n            \n            et al. \n          Accuracy of pleural biopsy using thoracoscopy for the diagnosis of histologic subtype in patients with malignant pleural mesothelioma. Cancer. 2007;110(10):2248\u20132252."},{"issue":"3","key":"i1543-2165-140-10-1104-b18","series-title":"Histopathology","first-page":"340","article-title":"The comparative accuracy of different pleural biopsy techniques in the diagnosis of malignant mesothelioma","volume":"53","author":"Attanoos \n              RL,","year":"2008","unstructured":"Attanoos \n              RL, \n            \n            \n              Gibbs \n              AR. \n            \n          \n          The comparative accuracy of different pleural biopsy techniques in the diagnosis of malignant mesothelioma. Histopathology. 2008;53(3):340\u2013344."},{"issue":"3","key":"i1543-2165-140-10-1104-b19","series-title":"J Thorac Oncol","first-page":"602","article-title":"Accuracy of diagnostic biopsy for the histological subtype of malignant pleural mesothelioma","volume":"6","author":"Kao \n              SC,","year":"2011","unstructured":"Kao \n              SC, \n            \n            \n              Yan \n              TD, \n            \n            \n              Lee \n              K, \n            \n            et al. \n          Accuracy of diagnostic biopsy for the histological subtype of malignant pleural mesothelioma. J Thorac Oncol. 2011;6(3):602\u2013605."},{"issue":"5","key":"i1543-2165-140-10-1104-b20","series-title":"Arch Pathol Lab Med","first-page":"647","article-title":"International Mesothelioma Interest Group. Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group","volume":"137","author":"Husain \n              AN,","year":"2013","unstructured":"Husain \n              AN, \n            \n            \n              Colby \n              T, \n            \n            \n              Ordonez \n              N, \n            \n            et al;\n          \n          International Mesothelioma Interest Group. Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med. 2013;137(5):647\u2013667."},{"issue":"10","key":"i1543-2165-140-10-1104-b21","series-title":"Am J Surg Pathol","first-page":"1264","article-title":"Benign mesothelial cells in mediastinal lymph nodes","volume":"23","author":"Parkash \n              V,","year":"1999","unstructured":"Parkash \n              V, \n            \n            \n              Vidwans \n              M, \n            \n            \n              Carter \n              D. \n            \n          \n          Benign mesothelial cells in mediastinal lymph nodes. Am J Surg Pathol. 1999;23(10):1264\u20131269."},{"issue":"2","key":"i1543-2165-140-10-1104-b22","series-title":"Indian J Med Paediatr Oncol","first-page":"62","article-title":"Mesothelial cell inclusions mimicking adenocarcinoma in cervical lymph nodes in association with chylous effusion","volume":"31","author":"Goyal \n              M,","year":"2010","unstructured":"Goyal \n              M, \n            \n            \n              Kodandapani \n              S, \n            \n            \n              Sharanabasappa \n              SN, \n            \n            \n              Palanki \n              SD. \n            \n          \n          Mesothelial cell inclusions mimicking adenocarcinoma in cervical lymph nodes in association with chylous effusion. Indian J Med Paediatr Oncol. 2010;31(2):62\u201364."},{"issue":"2","key":"i1543-2165-140-10-1104-b23","series-title":"Semin Diagn Pathol","first-page":"89","article-title":"Medicolegal liability in surgical pathology: a consideration of underlying causes and selected pertinent concepts","volume":"24","author":"Wick \n              MR.","year":"2007","unstructured":"Wick \n              MR. \n            \n          \n          Medicolegal liability in surgical pathology: a consideration of underlying causes and selected pertinent concepts. Semin Diagn Pathol. 2007;24(2):89\u201397."},{"issue":"3","key":"i1543-2165-140-10-1104-b24","series-title":"Eur Respir J","first-page":"754","article-title":"Multimodal management of malignant pleural mesothelioma: where are we today?","volume":"44","author":"Van Schil \n              PE,","year":"2014","unstructured":"Van Schil \n              PE, \n            \n            \n              Opitz \n              I, \n            \n            \n              Weder \n              W, \n            \n            et al. \n          Multimodal management of malignant pleural mesothelioma: where are we today?\n          Eur Respir J. 2014;44(3):754\u2013764."},{"issue":"9","key":"i1543-2165-140-10-1104-b25","series-title":"J Clin Oncol","first-page":"1413","article-title":"Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma","volume":"27","author":"de Perrot \n              M,","year":"2009","unstructured":"de Perrot \n              M, \n            \n            \n              Feld \n              R, \n            \n            \n              Cho \n              BC, \n            \n            et al. \n          Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. J Clin Oncol. 2009;27(9):1413\u20131418."},{"issue":"9","key":"i1543-2165-140-10-1104-b26","series-title":"Clin Cancer Res","first-page":"3303","article-title":"P16 loss and mitotic activity predict poor survival in patients with peritoneal malignant mesothelioma","volume":"11","author":"Borczuk \n              AC,","year":"2005","unstructured":"Borczuk \n              AC, \n            \n            \n              Taub \n              RN, \n            \n            \n              Hesdorffer \n              M, \n            \n            et al. \n          P16 loss and mitotic activity predict poor survival in patients with peritoneal malignant mesothelioma. Clin Cancer Res. 2005;11(9):3303\u20133308."},{"issue":"5","key":"i1543-2165-140-10-1104-b27","series-title":"Histopathology","first-page":"729","article-title":"Prognostic significance of morphologic subtypes and mitotic index of epithelioid malignant peritoneal mesothelioma","volume":"68","author":"Krasinskas \n              AM,","year":"2016","unstructured":"Krasinskas \n              AM, \n            \n            \n              Borczuk \n              AC, \n            \n            \n              Hartman \n              DJ, \n            \n            et al. \n          Prognostic significance of morphologic subtypes and mitotic index of epithelioid malignant peritoneal mesothelioma. Histopathology. 2016;68(5):729\u2013737."},{"issue":"7","key":"i1543-2165-140-10-1104-b28","series-title":"Hum Pathol","first-page":"585","article-title":"The second diagnosis: the role of the pathologist in identifying pneumoconioses in lungs excised for tumor","volume":"12","author":"Mark \n              EJ.","year":"1981","unstructured":"Mark \n              EJ. \n            \n          \n          The second diagnosis: the role of the pathologist in identifying pneumoconioses in lungs excised for tumor. Hum Pathol. 1981;12(7):585\u2013587."},{"issue":"3","key":"i1543-2165-140-10-1104-b29","series-title":"Arch Pathol Lab Med","first-page":"462","article-title":"Pathology of asbestosis\u2014an update of the diagnostic criteria: report of the asbestosis committee of the College of American Pathologists and Pulmonary Pathology Society","volume":"134","author":"Roggli \n              VL,","year":"2010","unstructured":"Roggli \n              VL, \n            \n            \n              Gibbs \n              AR, \n            \n            \n              Attanoos \n              R, \n            \n            et al. \n          Pathology of asbestosis\u2014an update of the diagnostic criteria: report of the asbestosis committee of the College of American Pathologists and Pulmonary Pathology Society. Arch Pathol Lab Med. 2010;134(3):462\u2013480."},{"issue":"4","key":"i1543-2165-140-10-1104-b30","series-title":"Arch Pathol Lab Med","first-page":"318","article-title":"New markers for separating benign from malignant mesothelial proliferations: are we there yet","volume":"140","author":"Churg \n              A,","year":"2016","unstructured":"Churg \n              A, \n            \n            \n              Sheffield \n              BS, \n            \n            \n              Galateau-Salle \n              F. \n            \n          \n          New markers for separating benign from malignant mesothelial proliferations: are we there yet. Arch Pathol Lab Med. 2016;140(4):318\u2013321."},{"issue":"6","key":"i1543-2165-140-10-1104-b31","series-title":"Virchows Arch","first-page":"627","article-title":"Prognostic significance of p16\/CDKN2A loss in pleural malignant mesotheliomas","volume":"453","author":"Dacic \n              S,","year":"2008","unstructured":"Dacic \n              S, \n            \n            \n              Kothmaier \n              H, \n            \n            \n              Land \n              S, \n            \n            et al. \n          Prognostic significance of p16\/CDKN2A loss in pleural malignant mesotheliomas. Virchows Arch. 2008;453(6):627\u2013635."},{"issue":"6","key":"i1543-2165-140-10-1104-b32","series-title":"Cancer Res","first-page":"2970","article-title":"Global gene expression profiling of pleural mesotheliomas: overexpression of aurora kinases and P16\/CDKN2A deletion as prognostic factors and critical evaluation of microarray-based prognostic prediction","volume":"66","author":"Lopez-Rios \n              F,","year":"2006","unstructured":"Lopez-Rios \n              F, \n            \n            \n              Chuai \n              S, \n            \n            \n              Flores \n              R, \n            \n            et al. \n          Global gene expression profiling of pleural mesotheliomas: overexpression of aurora kinases and P16\/CDKN2A deletion as prognostic factors and critical evaluation of microarray-based prognostic prediction. Cancer Res. 2006;66(6):2970\u20132979."},{"issue":"3","key":"i1543-2165-140-10-1104-b33","series-title":"Nat Rev Cancer","first-page":"153","article-title":"BAP1 and cancer","volume":"13","author":"Carbone \n              M,","year":"2013","unstructured":"Carbone \n              M, \n            \n            \n              Yang \n              H, \n            \n            \n              Pass \n              HI, \n            \n            \n              Krausz \n              T, \n            \n            \n              Testa \n              JR, \n            \n            \n              Gaudino \n              G. \n            \n          \n          BAP1 and cancer. Nat Rev Cancer. 2013;13(3):153\u2013159."},{"issue":"1","key":"i1543-2165-140-10-1104-b34","series-title":"Carcinogenesis","first-page":"76","article-title":"Mesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survival","volume":"36","author":"Baumann \n              F,","year":"2015","unstructured":"Baumann \n              F, \n            \n            \n              Flores \n              E, \n            \n            \n              Napolitano \n              A, \n            \n            et al. \n          Mesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survival. Carcinogenesis. 2015;36(1):76\u201381."},{"issue":"1","key":"i1543-2165-140-10-1104-b35","series-title":"Am J Clin Pathol","first-page":"85","article-title":"Comparative immunohistochemical analysis of IMP3, GLUT1, EMA, CD146, and desmin for distinguishing malignant mesothelioma from reactive mesothelial cells","volume":"141","author":"Minato \n              H,","year":"2014","unstructured":"Minato \n              H, \n            \n            \n              Kurose \n              N, \n            \n            \n              Fukushima \n              M, \n            \n            et al. \n          Comparative immunohistochemical analysis of IMP3, GLUT1, EMA, CD146, and desmin for distinguishing malignant mesothelioma from reactive mesothelial cells. Am J Clin Pathol. 2014;141(1):85\u201393."},{"issue":"7","key":"i1543-2165-140-10-1104-b36","series-title":"Arch Pathol Lab Med","first-page":"804","article-title":"Utility of glucose transporter 1 in the distinction of benign and malignant thoracic and abdominal mesothelial lesions","volume":"136","author":"Lagana \n              SM,","year":"2012","unstructured":"Lagana \n              SM, \n            \n            \n              Taub \n              RN, \n            \n            \n              Borczuk \n              AC. \n            \n          \n          Utility of glucose transporter 1 in the distinction of benign and malignant thoracic and abdominal mesothelial lesions. Arch Pathol Lab Med. 2012;136(7):804\u2013809."},{"issue":"4","key":"i1543-2165-140-10-1104-b37","series-title":"Am J Clin Pathol","first-page":"619","article-title":"The diagnostic utility of p16 FISH and GLUT-1 immunohistochemical analysis in mesothelial proliferations","volume":"135","author":"Monaco \n              SE,","year":"2011","unstructured":"Monaco \n              SE, \n            \n            \n              Shuai \n              Y, \n            \n            \n              Bansal \n              M, \n            \n            \n              Krasinskas \n              AM, \n            \n            \n              Dacic \n              S. \n            \n          \n          The diagnostic utility of p16 FISH and GLUT-1 immunohistochemical analysis in mesothelial proliferations. Am J Clin Pathol. 2011;135(4):619\u2013627."},{"issue":"3","key":"i1543-2165-140-10-1104-b38","series-title":"Am J Surg Pathol","first-page":"421","article-title":"IMP3 and GLUT-1 immunohistochemistry for distinguishing benign from malignant mesothelial proliferations","volume":"37","author":"Lee \n              AF,","year":"2013","unstructured":"Lee \n              AF, \n            \n            \n              Gown \n              AM, \n            \n            \n              Churg \n              A. \n            \n          \n          IMP3 and GLUT-1 immunohistochemistry for distinguishing benign from malignant mesothelial proliferations. Am J Surg Pathol. 2013;37(3):421\u2013426."},{"issue":"7","key":"i1543-2165-140-10-1104-b39","series-title":"Am J Surg Pathol","first-page":"866","article-title":"Localized malignant mesothelioma","volume":"29","author":"Allen \n              TC,","year":"2005","unstructured":"Allen \n              TC, \n            \n            \n              Cagle \n              PT, \n            \n            \n              Churg \n              AM, \n            \n            et al. \n          Localized malignant mesothelioma. Am J Surg Pathol. 2005;29(7):866\u2013873."}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"link":[{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/140\/10\/article-p1104.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/140\/10\/1104\/1615041\/arpa_2016-0073-oa.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aplm.kglmeridian.com\/downloadpdf\/journals\/arpa\/140\/10\/article-p1104.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aplm.kglmeridian.com\/downloadpdf\/journals\/arpa\/140\/10\/article-p1104.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T01:05:58Z","timestamp":1770771958000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/140\/10\/article-p1104.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":78,"journal-issue":{"issue":"10"},"URL":"https:\/\/doi.org\/10.5858\/arpa.2016-0073-oa","relation":{},"ISSN":["0003-9985","1543-2165"],"issn-type":[{"value":"0003-9985","type":"print"},{"value":"1543-2165","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10]]}}}